D‐penicillamine in the treatment of rheumatoid arthritis
Open Access
- 1 March 1977
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 20 (2), 666-670
- https://doi.org/10.1002/art.1780200205
Abstract
Forty-four patients with definite or classic rheumatoid arthritis and failure to tolerate or respond to gold therapy were treated with D-penicillamine on a so-called go-slow, go-low regime. Seventeen patients tolerated the drug and had a 3−13 month follow-up assessment; 8 were markedly improved, 6 moderately or slightly improved, and 3 unimproved. Penicillamine had to be discontinued in 9 patients because of toxic side effects.This publication has 8 references indexed in Scilit:
- Synthetic D(-)penicillamine in rheumatoid arthritis. Double-blind controlled study of a high and low dosage regimen.Annals Of The Rheumatic Diseases, 1975
- The technique of penicillamine administration in rheumatoid arthritisArthritis & Rheumatism, 1975
- Trial comparing D-penicillamine and gold in rheumatoid arthritis. Preliminary report.Annals Of The Rheumatic Diseases, 1974
- Penicillamine in Rheumatoid Disease: A Long-term StudyBMJ, 1974
- CONTROLLED TRIAL OF D(-)PENICILLAMINE IN SEVERE RHEUMATOID ARTHRITISThe Lancet, 1973
- Observations on the treatment of rheumatoid disease with penicillaminePublished by Oxford University Press (OUP) ,1970
- D‐Penicillamine in rheumatoid arthritisArthritis & Rheumatism, 1970
- Rheumatoid Arthritis with ArteritisAnnals of Internal Medicine, 1964